Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ASIX
ASIX logo

ASIX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy AdvanSix Inc (ASIX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
22.250
1 Day change
3.15%
52 Week Range
25.940
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

AdvanSix Inc (ASIX) is not a strong buy for a beginner investor with a long-term strategy at this time. The company's financial performance shows significant challenges, particularly with a sharp drop in net income and EPS. Technical indicators are neutral, and there are no strong trading signals or positive catalysts to suggest immediate upside potential. Given the lack of recent news, weak analyst sentiment, and no significant insider or hedge fund activity, it is better to hold off on investing in this stock for now.

Technical Analysis

The MACD is negative and contracting (-0.288), RSI is neutral (50.564), and moving averages are converging, indicating no clear trend. The stock is trading near its support level (S1: 23.082) but shows no strong bullish momentum.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
10

Positive Catalysts

  • Gross margin increased significantly (up 121.57% YoY) in Q4 2025, showing some operational efficiency improvements.

Neutral/Negative Catalysts

  • Analysts have a Hold rating with a modest price target increase, citing near-term input cost inflation pressures.

Financial Performance

In Q4 2025, revenue increased by 9.39% YoY to $359.95M. However, net income dropped to -$2.79M, and EPS fell to -$0.1. Despite a rise in gross margin to 7.6%, the overall financial performance is weak.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Truist raised the price target to $20 from $19 but maintained a Hold rating, citing near-term input cost pressures and EBITDA challenges despite cost rationalization efforts.

Wall Street analysts forecast ASIX stock price to fall
1 Analyst Rating
Wall Street analysts forecast ASIX stock price to fall
0 Buy
1 Hold
0 Sell
Hold
Current: 21.570
sliders
Low
19
Averages
19
High
19
Current: 21.570
sliders
Low
19
Averages
19
High
19
Truist
Hold
maintain
$19 -> $20
AI Analysis
2026-02-23
Reason
Truist
Price Target
$19 -> $20
AI Analysis
2026-02-23
maintain
Hold
Reason
Truist raised the firm's price target on AdvanSix to $20 from $19 and keeps a Hold rating on the shares. Input cost inflation is in the near term overshadowing the benefits of a relatively favorable growth outlook for the Plant Nutrients business, the analyst tells investors in a research note. AdvanSix is undergoing efforts to rationalize costs and capital spending, which should support positive free cash flow generation in 2026 despite what the firm expects to be meaningful y/y EBITDA pressure, Truist adds.
Piper Sandler
Piper Sandler
Neutral
to
Overweight
upgrade
$26 -> $32
2025-05-19
Reason
Piper Sandler
Piper Sandler
Price Target
$26 -> $32
2025-05-19
upgrade
Neutral
to
Overweight
Reason
Piper Sandler last night upgraded AdvanSix to Overweight from Neutral with a price target of $32, up from $26. The firm cites the earnings benefit of the ammonium sulfate business as well as the relatively small impact of tariffs and the nylon, nylon intermediate and chemical intermediate businesses for the upgrade. Piper sees AdvanSix's earnings holding up better than most other chemical shares. AdvanSix's EBITDA is "far from a peak level," making the shares "significantly undervalued," Piper contends.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ASIX
Unlock Now

People Also Watch